Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 1, Pages 212-219
Publisher
Wiley
Online
2016-02-26
DOI
10.1002/ijc.30062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antihypertensive medication use and incident breast cancer in women
- (2015) Elizabeth E. Devore et al. BREAST CANCER RESEARCH AND TREATMENT
- β-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer
- (2015) Minas Sakellakis et al. CHEMOTHERAPY
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- (2015) Eddy Pasquier et al. Oncotarget
- Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts
- (2014) Chris R Cardwell et al. BMC Medicine
- Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
- (2014) Denise M. Boudreau et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort
- (2014) Chris R Cardwell et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
- (2013) Michelle D. Holmes et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
- (2013) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
- (2013) Gitte Vrelits Sørensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
- (2013) Young Kwang Chae et al. Journal of Cancer
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
- (2011) Patricia A. Ganz et al. BREAST CANCER RESEARCH AND TREATMENT
- Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
- (2011) Sunil M. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Using β-blockers to inhibit breast cancer progression
- (2011) Desmond G. Powe et al. Nature Reviews Clinical Oncology
- Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
- (2010) Joan A. Largent et al. CANCER CAUSES & CONTROL
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
- (2010) E. K. Sloan et al. CANCER RESEARCH
- Host Factors and Cancer Outcome
- (2010) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Weight, Physical Activity, Diet, and Prognosis in Breast and Gynecologic Cancers
- (2010) Anne McTiernan et al. JOURNAL OF CLINICAL ONCOLOGY
- Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
- (2010) Susan K. Lutgendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Alcohol Consumption and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer: The Life After Cancer Epidemiology Study
- (2010) Marilyn L. Kwan et al. JOURNAL OF CLINICAL ONCOLOGY
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
- (2010) Kimberly S. Peairs et al. JOURNAL OF CLINICAL ONCOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications
- (2010) Gavin W. Lambert et al. PHARMACOLOGY & THERAPEUTICS
- Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells
- (2010) Sylvie Lamy et al. VASCULAR PHARMACOLOGY
- The association of metabolic syndrome with triple-negative breast cancer
- (2009) B. Maiti et al. BREAST CANCER RESEARCH AND TREATMENT
- Is it Time to Test Metformin in Breast Cancer Clinical Trials?
- (2009) M. Cazzaniga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Model of Gene-Environment Interaction Reveals Altered Mammary Gland Gene Expression and Increased Tumor Growth following Social Isolation
- (2009) J. B. Williams et al. Cancer Prevention Research
- Adrenoceptors: Non Conventional Target for Breast Cancer?
- (2009) I Luthy et al. CURRENT MEDICINAL CHEMISTRY
- β-Blocker Use for the Stages of Heart Failure
- (2009) Marc Klapholz MAYO CLINIC PROCEEDINGS
- Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion
- (2009) Borhane Annabi et al. PHARMACOLOGICAL RESEARCH
- Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer
- (2008) Bette J. Caan et al. CANCER CAUSES & CONTROL
- Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population
- (2008) L. Vona-Davis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The renin-angiotensin system and malignancy
- (2008) E. I. Ager et al. CARCINOGENESIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started